Nezam El-Tayebat 事实核查对“نظام الطيبات”饮食体系的科学评估
选择国家
选择语言: 简体中文

错误 已被科学证据否定 证据确定性: 高 初步 C-INS-08

糖尿病酮症酸中毒（DKA）不会致人死亡；应该用皮质类固醇治疗，并连续几天完全不吃不喝，不用胰岛素，也不输液；在这种情况下使用胰岛素是“黑色灾难”。

安全提示: 血糖升高同时尿液或血液中出现酮体（丙酮），尤其伴有恶心、呕吐、腹痛、呼吸急促、口渴或嗜睡时，可能意味着糖尿病酮症酸中毒，这是一种医疗急症。在使用SGLT2抑制剂（例如达格列净/Forxiga、恩格列净）的人中，酮症酸中毒可能在血糖正常或仅轻度升高时发生。请立即寻求急诊治疗；不要等待，也不要试图靠禁食熬过去。请不要因为这一说法而停用或减少胰岛素。在1型糖尿病和其他胰岛素缺乏的情况下，停用胰岛素会在数小时至数天内导致糖尿病酮症酸中毒，这会危及生命。医学界公认的立场（ADA Standards of Care 2026）：胰岛素治疗对1型糖尿病患者是必不可少的；接受强化胰岛素治疗的人即使不进食，也不应停用基础胰岛素。糖尿病药物的任何调整都应与主治医生共同进行。皮质类固醇和不喝水的禁食都不是酮症酸中毒的治疗方法。不补充液体会加重酮症酸中毒时的严重脱水，而在缺乏胰岛素时，禁食会加速酮体的积聚。
简而言之: 该说法错误。在胰岛素问世之前，糖尿病酮症酸中毒几乎总是致命的；在苏格兰，50岁以下1型糖尿病患者的死亡中，仍有约五分之一是由酮症酸中毒或糖尿病昏迷造成的；它主要由缺乏胰岛素引起，需要用胰岛素、静脉输液和补钾来治疗，而皮质类固醇会升高血糖，不喝水的禁食会加速酮症酸中毒的发展。
结论: 糖尿病酮症酸中毒（DKA）不加治疗会致命，主要由缺乏胰岛素引起；胰岛素、补液和补钾能挽救生命，而可的松和不吃不喝的禁食会使病情恶化。
  1. 原始表述
  2. 科学评估
  3. 科学证据详解
  4. 通俗解释
  5. 与该说法相关的研究
  6. 地区背景
  7. 在我的国家适用什么？
  8. 参考文献

原始表述

مش عايز محاليل محاليل ايه كورتيكوست لحد ما يفك وصيام اكل وشرب ان بي او لا ايام مش عايز علاج ديكي ايه

按来源为原话. 译文由本项目提供；以阿拉伯语原文为准。

译文

糖尿病酮症酸中毒（DKA）不会致人死亡；应该用皮质类固醇治疗，并连续几天完全不吃不喝，不用胰岛素，也不输液；在这种情况下使用胰岛素是“黑色灾难”。

出处

来源状态
视频转录文本（本人原话）
归属
Elawady (machine transcript)
视频
الغيبوبات السكرية ؟! (打开来源)
发布日期
2025年4月30日
时间戳
0:49:40 (在原视频 YouTube 自动字幕轨中的位置；可确认该内容出现的位置，但不能确认说话人是谁)
归属的不确定性
Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.
所声称的机制

Coma in DKA is due to blood pooling in a congested liver/gut; cortisone restores circulation; ketones and glucose are liver products.

所声称的健康影响

Denial of DKA as deadly; rejection of insulin and fluids in DKA

涉及人群

People with diabetes in hyperglycaemic crisis

Elawady 设定的地域限制

none found

来源版本存在差异

来源状态
视频转录文本（本人原话）
归属
Elawady (machine transcript)
视频
Dr Diaa Al Awady د ضياء العوضي is live! البروستاتا البنكرياس الكلي الخصيتين ايه وجه الشبه بينهم ؟! (打开来源)
发布日期
2025年8月29日
时间戳
无（转录文本不含时间信息）
归属的不确定性
Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.
来源状态
视频转录文本（本人原话）
归属
Elawady (machine transcript)
视频
Dr Diaa Al Awady د ضياء العوضي is live! النسيج البيني التعرق التبول ؟!! (打开来源)
发布日期
2025年10月15日
时间戳
无（转录文本不含时间信息）
归属的不确定性
Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.

科学评估

错误 – 该说法与可靠证据相矛盾。

证据确定性: 高 – 进一步研究极不可能改变该评估。

1. 说法是什么？

DKA is harmless; treatment should be cortisone plus multi-day fasting without food, drink, insulin or fluids.

2. 哪些内容可证实是正确的？

Elawady correctly lists three hyperglycaemic emergencies (DKA, hyperosmolar state, lactic acidosis), correctly notes that SGLT2 inhibitors can cause ketoacidosis, sometimes with near-normal glucose (I-ODD-10), and that ketosis occurs in starvation. Fasting can lower blood glucose during insulin deficiency (I-INS-112), and with modern treatment DKA deaths are rare (no deaths among 919 treated children in Middle Eastern ICUs, I-INS-114), which may explain the impression that 'nobody dies' of DKA; this low mortality is the result of insulin and fluids.

3. 哪些内容是错误或夸大的？

DKA is a life-threatening emergency. The 2024 consensus states: 'Insulin therapy is the cornerstone of DKA management and should be started as soon as possible after diagnosis', with isotonic fluids at 500-1,000 mL/h initially and potassium replacement; 'Appropriate treatment has reduced mortality owing to DKA to <1%' (I-INS-07). Without optimal treatment DKA has 'appreciable, although largely preventable, morbidity and mortality' (I-INS-08). In the canagliflozin programme, DKA cases were driven by insulin deficiency (autoimmune diabetes, insulin omission or dose reduction) and acute illness, with glucose above 300 mg/dL, which supports insulin treatment rather than withholding it (A-ODD-10). Patients with DKA are severely dehydrated, so withholding fluids and imposing a dry fast would worsen shock and kidney failure. Glucocorticoids 'may precipitate acute and sustained hyperglycemia by countering insulin action' (I-INS-07). The hypothesis of hepatic/intestinal blood pooling as the cause of DKA coma has no supporting evidence.

4. 哪些内容仍不明确？

Nothing material.

5. 哪些研究支持该说法？

None for the treatment claim.

6. 哪些研究与该说法相矛盾？

I-INS-07, I-INS-08, I-INS-10, A-ODD-10, I-INS-130, I-INS-136 (guidelines); I-INS-101 (pre-insulin era: diabetic coma was the usual cause of death); I-INS-111 (DKA/coma 22% of deaths in T1D under 50 in Scotland); I-INS-108, I-INS-109 (stopping insulin causes about two-thirds of DKA); I-INS-110 (IV fluids safe); I-INS-112 (fasting and dehydration accelerate ketoacidosis); I-INS-115 (severe DKA common in Egyptian children).

7. 对德国和欧洲而言情况如何？

German and European emergency practice follows the same consensus (EASD and JBDS are co-authors of I-INS-07).

8. 关于埃及的已知情况是什么？

DKA is a common cause of emergency admission of children and young adults with diabetes in Egypt and the region; delayed treatment increases mortality. Advice to avoid hospitals and insulin is particularly dangerous where access to care is already delayed.

9. 合理的实际结论是什么？

怀疑出现糖尿病酮症酸中毒（DKA）时，需要立即接受急诊治疗，使用胰岛素、补液和补充电解质。皮质类固醇和禁食都不是DKA的治疗方法。

评估详情

证据确定性的依据

International consensus (ADA/EASD/JBDS/AACE/DTS 2024) based on decades of evidence: insulin is 'the cornerstone of DKA management', with IV fluids and potassium. DKA mortality is <1% only with appropriate treatment. Glucocorticoids raise glucose and can precipitate hyperglycaemic crises. Elawady himself says in the same video that cortisone increases ketones and glucose.

来源质量

Own words, machine transcripts of two separate videos (identical lecture published as live and edited version).

地区可推广性

Universal.

个体例外情况

None.

说法的地域范围
普遍性（生物学/医学）
最近审核
2026年10月26日 初步

科学证据详解

已被科学证据否定 – 高质量证据显示情况恰恰相反，或该说法与已确立的生理学知识相矛盾。

研究问题: Is diabetic ketoacidosis non-lethal, and can it be treated with corticosteroids and complete fasting from food and water without insulin or intravenous fluids?

研究问题详解 (PICO)
人群
People with diabetes in ketoacidosis
干预或暴露
Corticosteroids plus dry fasting without insulin or IV fluids
对照
Guideline treatment (IV fluids, insulin, potassium)
地域范围
universal biology; Egyptian/Middle Eastern data
结局指标
  • Mortality
  • Resolution of acidosis
  • Cerebral oedema/neurological outcome

研究结果按作者报告呈现。我们的评估见下文。

哪些证据支持该说法？

哪些证据不支持该说法？

总体证据说明了什么？

基于上述研究的编辑评估——其本身并非研究结果。

哪种观点有更好的证据支持？

DKA is a life-threatening emergency caused mostly by insulin deficiency/omission; it is treated with IV fluids, insulin and potassium; glucocorticoids raise glucose; fasting and dehydration accelerate ketoacidosis.

为什么有些研究权重更大

Guidelines, RCT on fluids, national mortality data, physiological experiments and natural history agree; the only 'supporting' trial is implausible and indirect.

因果关系是否已确立？ 是，已确立 Insulin omission precipitates DKA (Musey, Randall); treatment with insulin and fluids lowered DKA mortality to <1%; untreated DKA was uniformly fatal before 1922.

仍存在的不确定性

None material for the claim.

合理的结论

False and potentially fatal advice.

为什么研究结果看起来互相矛盾？

'Nobody dies of DKA' may reflect experience with treated DKA, where mortality is <1% (I-INS-114 found 0 deaths in treated children); this is the result of insulin and fluids, not evidence that DKA is harmless.

这是否取决于国家？
一般生物学效应
Insulin physiology, autoimmune type 1 diabetes and ketoacidosis are universal human biology.
饮食习惯
Egyptian and European diets differ, but no dietary pattern replaces insulin in insulin-deficient diabetes.
食品原产地
Not relevant.
污染物
Not relevant.
本国生产条件
Not relevant.
法律规则
Insulin is an essential medicine (WHO list) in Egypt and the EU; prescription rules not relevant to the scientific question.
实际监测数据
In Cairo, 43% of children with T1D presenting to the emergency department had severe DKA, mostly at first diagnosis (I-INS-115); treated paediatric DKA in Middle Eastern ICUs had no deaths (I-INS-114). Advice to avoid insulin, fluids and hospitals would remove the treatment that makes DKA survivable.

足以改变结论的地区差异没有可靠数据支持。

统计复核
  • Plausibility of reported pH distribution – With mean 6.49 and SD 0.52, about half of patients would have pH <6.5 and about 17% <6.0; post-treatment SD implies 22% with pH >7.45 in the placebo arm; data implausible 已重新计算
  • Proportion of DKA due to insulin cessation (Wilson CI) – 28/42 = 66.7% (51.6-79.0%) 已重新计算
  • Proportion due to insulin discontinuation (reconstructed count) – about 111/164 = 67.7% (60.2-74.4%) 已重新计算
  • Brain injury rate with IV fluids (Wilson CI) – 12/1389 = 0.9% (0.5-1.5%) 已重新计算
总体证据的确定性（GRADE，简化版）
主要结局
Mortality of DKA treated without insulin and fluids
起始等级
低（观察性研究）
升级理由
  • very large effect (near-universal death before insulin vs <1% with treatment)
  • consistent mechanism
结果
高

由单名审查者参照 GRADE 方法进行的简化评估；并非正式的 GRADE 专家组评估。GRADE 评价的是针对某一结局的整体证据，而非单项研究。

已核查的临床指南和官方声明
  • ADA/EASD/JBDS/AACE/DTS: Hyperglycemic Crises in Adults With Diabetes: A Consensus Report (I-INS-07) (2024) · 原始文献
    Insulin is 'the cornerstone of DKA management'; isotonic fluids 500-1,000 mL/h initially; potassium replacement; treated DKA mortality <1%; glucocorticoids can precipitate hyperglycaemia.
  • ADA: 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2026 (2026) · 原始文献
    Rec 16.16 (A): manage DKA/HHS with intravenous fluids, insulin and electrolytes, close monitoring and treatment of the precipitating cause; glucocorticoids induce hyperglycaemia in 56-86% of hospitalised people.
  • ADA: 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026 (2026) · 原始文献
    People at risk for DKA should have ketone testing tools and sick-day advice; people on intensive insulin therapy should not stop or hold basal insulin even if not eating; caution with near-normal A1C goals in long-standing T2D using hypoglycaemia-prone drugs (ACCORD).
  • NICE: NG17 Type 1 diabetes in adults (last updated 17 August 2022) (2022) · 原始文献
    Basal-bolus insulin for all adults with T1D (1.7.1); ketone monitoring in sick-day rules (1.10.1); DKA: isotonic saline and IV insulin infusion (1.10.5-1.10.7).
  • NICE: NG18 Diabetes in children and young people (last updated 11 May 2023) (2023) · 原始文献
    Basal-bolus insulin from diagnosis (1.2.18); blood ketone testing and sick-day rules (1.2.82-1.2.83); DKA is serious and needs urgent hospital IV fluids and insulin (1.4.6, 1.4.21); DKA can occur with normal glucose (1.4.3).
  • JBDS-IP: The management of diabetic ketoacidosis in adults (2022 article; single-page pathway March 2023) (2023) · 原始文献
    Within the first hour: 0.9% saline and fixed-rate IV insulin 0.1 unit/kg/h, continue long-acting insulin, potassium replacement.
  • ADA/EASD: The management of type 1 diabetes in adults: updated 2026 consensus report (2026) · 原始文献
    'Lifelong insulin therapy is essential in type 1 diabetes'; all individuals need glucose and ketone testing supplies; insulin omission or under-dosing is a DKA precipitant.
  • ISPAD: ISPAD Clinical Practice Consensus Guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state (Glaser N et al., PMID 36250645) (2022) · 原始文献 无法获取；内容未采用
  • ISPAD: ISPAD 2022: Sick day management in children and adolescents with diabetes (Phelan H et al., PMID 36093857) (2022) · 原始文献 无法获取；内容未采用
检索策略

本次审查的文献检索记录（检索式采用原数据库语法）。

数据库日期检索式检索目标命中数纳入数
Europe PMC2026年10月26日("diabetic ketoacidosis" OR "hyperglycemic crisis") AND (glucocorticoid OR corticosteroid OR steroid OR dexamethasone) AND (precipitat* OR induced OR risk)支持性证据6061
PubMed2026年10月26日(glucocorticoid* OR corticosteroid*) AND ("hyperglycemic crisis" OR "hyperglycaemic emergenc*" OR "diabetic ketoacidosis") AND (cohort OR "case-control")支持性证据16
PubMed2026年10月26日(corticosteroid* OR glucocorticoid* OR dexamethasone OR hydrocortisone) AND "diabetic ketoacidosis"[ti] AND (treatment OR therapy OR management) AND (trial OR cohort OR outcome)支持性证据19
Europe PMC2026年10月26日TITLE:"diabetic ketoacidosis" AND (TITLE:"fasting" OR TITLE:"Ramadan")双向15
Europe PMC2026年10月26日("diabetic ketoacidosis") AND ("Middle East" OR Arab OR "MENA") AND (mortality) AND (TITLE:"systematic review" OR TITLE:"meta-analysis")双向52
PubMed2026年10月26日(diabetic ketoacidosis) AND (mortality) AND (systematic review[pt] OR meta-analysis[pt])反对性证据67
PubMed2026年10月26日("insulin omission" OR "cessation of insulin" OR "discontinuation of insulin") AND "diabetic ketoacidosis" AND (precipitat* OR cause)反对性证据72
PubMed2026年10月26日Musey VC[au] AND ketoacidosis反对性证据1
PubMed2026年10月26日Randall L[au] AND recurrent diabetic ketoacidosis反对性证据1
PubMed2026年10月26日Kuppermann N[au] AND "diabetic ketoacidosis" AND fluid[ti]反对性证据6
Europe PMC2026年10月26日"diabetic ketoacidosis" AND ("fluid" OR "saline") AND randomized AND children AND (cerebral OR neurologic) AND PUB_YEAR:[2015 TO 2026]反对性证据520
PubMed2026年10月26日"diabetic ketoacidosis" AND (mortality OR "case fatality") AND trends AND (population-based OR national)反对性证据36
PubMed2026年10月26日(glucocorticoid* OR corticosteroid*) AND hyperglycemia AND meta-analysis[pt]反对性证据112
PubMed2026年10月26日diabetic ketoacidosis AND (Egypt OR Egyptian) AND (mortality OR outcome)反对性证据38
Europe PMC2026年10月26日(TITLE:"Egypt" OR TITLE:"Egyptian") AND (TITLE:"ketoacidosis")反对性证据0
Europe PMC2026年10月26日(TITLE:"Egypt" OR TITLE:"Egyptian") AND TITLE:"type 1 diabetes" AND (mortality OR "insulin omission" OR adherence OR "ketoacidosis")反对性证据22
PubMed2026年10月26日Joint British Diabetes Societies diabetic ketoacidosis adults updated guideline指南3
Web search + abcd.care2026年10月26日JBDS-IP management of diabetic ketoacidosis in adults abcd.care 2023 guideline (pathway PDF fetched)指南10
PubMed2026年10月26日ISPAD Clinical Practice Consensus Guidelines 2022 diabetic ketoacidosis指南1
Web search + ispad.org2026年10月26日ISPAD Clinical Practice Consensus Guidelines 2022 diabetic ketoacidosis chapter pdf ispad.org (Wiley full text returned HTTP 403)指南9
PMC (publisher full text)2026年10月26日Fetched ADA Standards of Care 2026 sections 2, 6, 8, 10, 14, 16 at pmc.ncbi.nlm.nih.gov/articles/PMC12690183, PMC12690178, PMC12690172, PMC12690187, PMC12690182, PMC12690180指南6
Guideline websites (NICE)2026年10月26日Fetched https://www.nice.org.uk/guidance/ng17/chapter/Recommendations and /ng18/chapter/Recommendations指南2

待解决的问题

ISPAD 2022 DKA and sick-day chapters could not be read (publisher HTTP 403); not needed for the conclusion.

核查深度如何？

17 项相关研究：11 项核查了全文（其中 2 项进行了结构化偏倚风险评估），6 项基于摘要核查，0 项仅核查了文献信息。 尚未进行由两名独立审查者完成的正式评估，也尚未进行独立的人类专家审核。

最近一次科学审核: 2026年10月26日

评定结论的变更历史
  1. 2026年10月25日 · 第 1 阶段 · 初始评估: 错误 (高)
  2. 2026年10月26日 · 第 4 阶段（系统证据审查） · 在扩展证据后重新审查；评定结论不变: 错误 (高)
    Deep search added national mortality data, insulin-omission studies, an RCT on fluids, physiology of fasting/dehydration and Egyptian/Middle Eastern data. The only randomised 'supporting' study for steroids is implausible and indirect.
    新来源: I-INS-101 I-INS-108 I-INS-109 I-INS-110 I-INS-111 I-INS-112 I-INS-113 I-INS-114 I-INS-115 I-INS-130 I-INS-136

通俗解释

当身体内的胰岛素严重不足时，就会发生糖尿病酮症酸中毒：血糖和酸性物质升高，身体大量失水。这是一种急症。医院会通过静脉滴注补液，并使用胰岛素和钾等盐类进行治疗；接受这种治疗后，成年患者的死亡率低于每100人中1人。可的松会升高血糖，不喝水的禁食会加重脱水，因此这个视频中的建议可能是致命的。

与该说法相关的研究

支持该说法的研究 (0)

该组中没有研究。

与该说法相矛盾或限制该说法的研究 (15)

  • International guideline on diabetic ketoacidosis

    Umpierrez GE et al.. Diabetes Care 2024 · PMID 39052901 · DOI 10.2337/dci24-0032
    指南 / 立场声明独立交叉核查已核查全文★ 关键研究

    Insulin, fluids and potassium are the core treatment; with this, fewer than 1% of adults die.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Diagnosis and management of DKA and HHS in adults

    研究是如何开展的？

    International consensus report based on systematic examination of literature since 2009 (ADA, EASD, JBDS, AACE, DTS)

    研究了多少人、动物或样本？

    not applicable; Adults with diabetes

    实际发现了什么？

    Insulin is the cornerstone; glucocorticoids worsen hyperglycaemia.

    观察到的效应有多大？

    Mortality <1% with treatment

    研究结果对日常生活意味着什么？

    Ketoacidosis needs hospital treatment with insulin.

    该研究有哪些局限？

    Consensus, not trial

    它对 Elawady 的具体说法说明了什么？

    Directly contradicts C-INS-08; supports danger in C-FAST-03; contradicts C-INS-07, C-INS-10.

    研究结果是否适用于德国和欧洲？

    EASD and JBDS (UK) co-authored; directly applicable.

    从该研究中明确不能得出什么结论？

    Outcomes of untreated DKA quantitatively.

    科学细节 →

  • Review on diabetic ketoacidosis

    Dhatariya KK et al.. Nat Rev Dis Primers 2020 · PMID 32409703 · DOI 10.1038/s41572-020-0165-1
    叙述性综述独立交叉核查全文，含结构化偏倚风险评估

    DKA is an emergency that can kill; it is treated with fluids, insulin and salts, and insulin must not be stopped in type 1 diabetes even when not eating.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Epidemiology, pathogenesis, diagnosis and management of DKA

    研究是如何开展的？

    Narrative expert review (Nature Reviews Disease Primers)

    研究了多少人、动物或样本？

    not applicable; Adults and children with diabetes

    实际发现了什么？

    DKA is diagnosed by high glucose, ketones and acid; it kills <1% when treated in rich countries but up to 26-41% where treatment is lacking; treatment is fluids, insulin and potassium, and insulin must never be stopped in type 1 diabetes even when not eating.

    观察到的效应有多大？

    not applicable

    研究结果对日常生活意味着什么？

    DKA is an emergency.

    该研究有哪些局限？

    Narrative expert review without systematic methods; one author has research support from insulin makers.

    它对 Elawady 的具体说法说明了什么？

    Contradicts C-INS-08, C-INS-02, C-FAST-01, C-FAST-03.

    研究结果是否适用于德国和欧洲？

    International.

    从该研究中明确不能得出什么结论？

    Quantitative estimates.

    科学细节 →

  • ADA guideline 2026: blood sugar goals and emergencies

    American Diabetes Association Professional Practice Committee for Diabetes* . Diabetes Care 2026 · PMID 41358894 · DOI 10.2337/dc26-S006
    指南 / 立场声明独立交叉核查已核查全文★ 关键研究

    Most adults should aim for HbA1c below 7%, avoid low sugar, and measure ketones when at risk.

    该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 高 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Glycaemic goals, hypoglycaemia and hyperglycaemic crises

    研究是如何开展的？

    Clinical practice guideline (ADA Standards of Care 2026, Section 6)

    研究了多少人、动物或样本？

    not applicable; People with diabetes

    实际发现了什么？

    Individual targets; do not stop basal insulin when not eating.

    观察到的效应有多大？

    not applicable

    研究结果对日常生活意味着什么？

    Moderate targets and safety rules.

    该研究有哪些局限？

    US-centred; Partially read

    它对 Elawady 的具体说法说明了什么？

    Supports C-INS-04, C-INS-11; contradicts C-FAST-01, C-FAST-03, C-DIAB-02.

    研究结果是否适用于德国和欧洲？

    Consistent with EASD guidance.

    从该研究中明确不能得出什么结论？

    Not applicable.

    科学细节 →

  • Ketoacidosis with canagliflozin

    Erondu N et al.. Diabetes Care 2015 · PMID 26203064 · DOI 10.2337/dc15-1251
    其他被 Tayebat 档案网站引用全文，含结构化偏倚风险评估

    Ketoacidosis was rare (7 per 10,000 patients), often with insulin deficiency or triggers.

    该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 低 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Incidence of DKA with canagliflozin

    研究是如何开展的？

    Pooled safety analysis of randomised trials

    研究了多少人、动物或样本？

    17,596; Type 2 diabetes in canagliflozin program

    实际发现了什么？

    DKA 0.07%.

    观察到的效应有多大？

    0.52-0.76 vs 0.24 per 1,000 PY

    研究结果对日常生活意味着什么？

    Rare but real risk.

    该研究有哪些局限？

    Analysed and written by manufacturer employees; only 12 cases; based on investigator reports (may miss cases).

    它对 Elawady 的具体说法说明了什么？

    Supports C-ODD-02; mixed for C-INS-08.

    研究结果是否适用于德国和欧洲？

    Multinational/US/UK data; transferable to EU practice.

    从该研究中明确不能得出什么结论？

    Precise relative risk; that euglycaemic DKA is common (cases here had high glucose).

    科学细节 →

  • Stopping insulin is the main cause of ketoacidosis in an urban US hospital

    Musey VC et al.. Diabetes Care 1995 · PMID 7497857 · DOI 10.2337/diacare.18.4.483
    病例系列 / 病例报告独立交叉核查已核查摘要★ 关键研究

    Two out of three ketoacidosis episodes in people with known diabetes followed stopping insulin.

    Stopping insulin is the main trigger of DKA.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 低 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Find the causes of DKA.

    研究是如何开展的？

    Interviews and records of consecutive patients.

    研究了多少人、动物或样本？

    56 DKA episodes.

    实际发现了什么？

    Stopping insulin caused 67% of episodes in known diabetes.

    观察到的效应有多大？

    67% (95% CI about 52-79%).

    研究结果对日常生活意味着什么？

    Stopping insulin, even when not eating, can lead to ketoacidosis.

    该研究有哪些局限？

    Small, old, single centre.

    它对 Elawady 的具体说法说明了什么？

    Contradicts advice to treat or prevent DKA without insulin.

    研究结果是否适用于德国和欧洲？

    Mechanism universal; social reasons vary.

    从该研究中明确不能得出什么结论？

    Cannot give population rates.

    科学细节 →

  • Why people with diabetes end up in hospital with ketoacidosis again and again

    Randall L et al.. Diabetes Care 2011 · PMID 21775761 · DOI 10.2337/dc11-0701
    横断面研究独立交叉核查已核查摘要★ 关键研究

    In 164 adults admitted with ketoacidosis, stopping insulin was the main trigger in 68%.

    Insulin discontinuation caused 68% of DKA.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Find the drivers of recurrent DKA.

    研究是如何开展的？

    Bedside interviews.

    研究了多少人、动物或样本？

    164 adults.

    实际发现了什么？

    Insulin stopped in 68%.

    观察到的效应有多大？

    68% (about 60-74%).

    研究结果对日常生活意味着什么？

    Stopping insulin is dangerous.

    该研究有哪些局限？

    Single centre.

    它对 Elawady 的具体说法说明了什么？

    Contradicts insulin-free management of DKA.

    研究结果是否适用于德国和欧洲？

    Mechanism universal.

    从该研究中明确不能得出什么结论？

    Cannot give population incidence.

    科学细节 →

  • How fast to give drip fluids to children with ketoacidosis

    Kuppermann N et al.. N Engl J Med 2018 · PMID 29897851 · DOI 10.1056/NEJMoa1716816
    随机对照试验独立交叉核查已核查摘要★ 关键研究

    Faster or slower fluids, with more or less salt, gave the same brain outcomes; brain injury was rare (0.9%).

    IV fluid therapy (with insulin) is safe across rates; no basis for withholding fluids.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Test fluid rates and types in childhood DKA.

    研究是如何开展的？

    Randomised trial, 13 hospitals.

    研究了多少人、动物或样本？

    1,389 DKA episodes.

    实际发现了什么？

    No differences between fluid strategies.

    观察到的效应有多大？

    Brain injury 0.9% overall.

    研究结果对日常生活意味着什么？

    Drip fluids, given with insulin, are a safe part of DKA treatment.

    该研究有哪些局限？

    Did not compare against no fluids.

    它对 Elawady 的具体说法说明了什么？

    Contradicts 'no IV fluids' in DKA.

    研究结果是否适用于德国和欧洲？

    Applicable to Europe.

    从该研究中明确不能得出什么结论？

    Cannot say anything about steroid treatment.

    科学细节 →

  • Why young people with type 1 diabetes die in Scotland

    O'Reilly JE et al.. Diabetologia 2020 · PMID 32451572 · DOI 10.1007/s00125-020-05173-w
    队列研究独立交叉核查已核查全文★ 关键研究

    Ketoacidosis or diabetic coma caused about one in five deaths before age 50, and four in five of these deaths happened outside hospital.

    DKA/coma caused 22% of deaths in T1D under 50; 79% outside hospital.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Analyse trends and causes of early death in T1D.

    研究是如何开展的？

    National register linkage.

    研究了多少人、动物或样本？

    27,935 people, 1138 deaths.

    实际发现了什么？

    DKA/coma 22% of deaths; mostly out of hospital.

    观察到的效应有多大？

    SMR 3-4.

    研究结果对日常生活意味着什么？

    Ketoacidosis remains a leading killer, especially when not treated in hospital.

    该研究有哪些局限？

    Combines DKA and hypoglycaemic coma.

    它对 Elawady 的具体说法说明了什么？

    Contradicts 'DKA does not kill anyone'.

    研究结果是否适用于德国和欧洲？

    UK data, directly applicable.

    从该研究中明确不能得出什么结论？

    Cannot separate DKA from hypoglycaemia deaths exactly.

    科学细节 →

  • Fasting, lack of water and ketoacidosis in type 1 diabetes

    Burge MR et al.. Metabolism 2001 · PMID 11229425 · DOI 10.1053/meta.2001.20194
    其他独立交叉核查已核查摘要★ 关键研究

    When insulin was stopped, prior fasting lowered blood sugar but made ketones and acid build up faster; lack of water raised both sugar and ketones.

    Fasting and dehydration accelerate ketosis and acidosis during insulin deficiency; fasting lowers glucose (kernel).

    该研究是否支持这一具体说法？ 否 · 方法学质量: 中 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Study how fasting and dehydration influence DKA development.

    研究是如何开展的？

    Short insulin withdrawal experiments.

    研究了多少人、动物或样本？

    25 adults with T1D.

    实际发现了什么？

    Fasting: lower glucose but faster ketosis; dehydration: higher glucose and faster ketosis.

    观察到的效应有多大？

    Not given in abstract.

    研究结果对日常生活意味着什么？

    Fasting can hide danger: sugar falls while acid rises.

    该研究有哪些局限？

    Small study.

    它对 Elawady 的具体说法说明了什么？

    Contradicts dry fasting as DKA treatment.

    研究结果是否适用于德国和欧洲？

    Universal physiology.

    从该研究中明确不能得出什么结论？

    Cannot give clinical outcome rates.

    科学细节 →

  • Ketoacidosis in Egyptian children with type 1 diabetes during COVID-19

    Abdou M et al.. Front Endocrinol (Lausanne) 2022 · PMID 35360079 · DOI 10.3389/fendo.2022.814991
    横断面研究独立交叉核查已核查摘要★ 关键研究

    43% of 324 children arrived with severe ketoacidosis, often at first diagnosis; delays made it worse.

    Severe DKA common in Egyptian children; delay worsens severity.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 低 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Describe DKA in Egyptian children during COVID-19.

    研究是如何开展的？

    Hospital records, Cairo.

    研究了多少人、动物或样本？

    324 children.

    实际发现了什么？

    43% severe DKA; two-thirds new diagnoses.

    观察到的效应有多大？

    43.2% severe DKA.

    研究结果对日常生活意味着什么？

    Late arrival at hospital makes ketoacidosis more dangerous.

    该研究有哪些局限？

    Single centre.

    它对 Elawady 的具体说法说明了什么？

    Contradicts delaying insulin and hospital care.

    研究结果是否适用于德国和欧洲？

    Egyptian setting.

    从该研究中明确不能得出什么结论？

    Cannot give death rates.

    科学细节 →

  • US diabetes standards 2026: hospital care and ketoacidosis

    American Diabetes Association Professional Practice Committee for Diabetes. Diabetes Care 2026 · PMID 41358892 · DOI 10.2337/dc26-S016
    指南 / 立场声明独立交叉核查已核查全文★ 关键研究

    Ketoacidosis must be treated with drip fluids, insulin and salts such as potassium; steroids raise blood sugar.

    Rec 16.16 (A): IV fluids, insulin, electrolytes; glucocorticoids cause hyperglycaemia.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Guide hospital diabetes care.

    研究是如何开展的？

    Evidence-graded guideline.

    研究了多少人、动物或样本？

    Not applicable.

    实际发现了什么？

    DKA = life-threatening; fluids + insulin + electrolytes (grade A).

    观察到的效应有多大？

    Not applicable.

    研究结果对日常生活意味着什么？

    Ketoacidosis is an emergency for hospital treatment.

    该研究有哪些局限？

    Guideline.

    它对 Elawady 的具体说法说明了什么？

    Contradicts C-INS-08 directly.

    研究结果是否适用于德国和欧洲？

    Same approach in Europe (JBDS, NICE).

    从该研究中明确不能得出什么结论？

    Not applicable.

    科学细节 →

  • UK protocol for treating ketoacidosis in adults

    Dhatariya KK et al. (JBDS-IP). Diabet Med 2022 · PMID 35224769 · DOI 10.1111/dme.14788
    指南 / 立场声明独立交叉核查已核查全文★ 关键研究

    Treatment starts within the first hour with drip fluids and an insulin infusion, plus potassium.

    IV saline and fixed-rate IV insulin within the first hour.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Guide adult DKA treatment.

    研究是如何开展的？

    National guideline and pathway.

    研究了多少人、动物或样本？

    Not applicable.

    实际发现了什么？

    Saline + insulin 0.1 unit/kg/h from the first hour.

    观察到的效应有多大？

    Not applicable.

    研究结果对日常生活意味着什么？

    Ketoacidosis needs fluids and insulin straight away.

    该研究有哪些局限？

    Guideline.

    它对 Elawady 的具体说法说明了什么？

    Contradicts C-INS-08.

    研究结果是否适用于德国和欧洲？

    UK/European practice.

    从该研究中明确不能得出什么结论？

    Not applicable.

    科学细节 →

  • What happened to people with diabetes before insulin existed

    Mazur A. Nutr J 2011 · PMID 21396115 · DOI 10.1186/1475-2891-10-23
    叙述性综述独立交叉核查已核查全文★ 关键研究

    Before 1922, children with diabetes usually died of diabetic coma within months to a few years, even on strict fasting diets; some starved to death.

    Diabetic coma (ketoacidosis) was 'always the cause of death' in Joslin's child patients; fasting did not prevent death.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 低 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    To explain why fasting diets were used for diabetes before insulin and how patients fared.

    研究是如何开展的？

    Historical analysis of published case series and textbooks.

    研究了多少人、动物或样本？

    Patients of Allen (76 published cases) and Joslin, 1914-1922.

    实际发现了什么？

    Most children died of coma within months to years; 43% of Allen's cases were dead by 1917; four died of starvation; diabetes was not cured.

    观察到的效应有多大？

    43% mortality within a few years (Allen's series).

    研究结果对日常生活意味着什么？

    Diet and fasting alone cannot keep insulin-deficient diabetes alive; insulin changed this.

    该研究有哪些局限？

    Historical, uncontrolled data; diabetes types not distinguished.

    它对 Elawady 的具体说法说明了什么？

    Contradicts claims that diet can replace insulin or that ketoacidosis does not kill.

    研究结果是否适用于德国和欧洲？

    Universal biology.

    从该研究中明确不能得出什么结论？

    Cannot give exact survival curves or separate type 1 from type 2 cases.

    科学细节 →

  • NICE guideline NG17: Type 1 diabetes in adults: diagnosis and management

    National Institute for Health and Care Excellence (NICE). NICE guideline 2015
    指南 / 立场声明独立交叉核查已核查全文★ 关键研究

    UK guideline: insulin is standard for all adults with T1D; DKA treated with IV saline and IV insulin.

    DKA: isotonic saline and IV insulin infusion.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    National guidance.

    研究是如何开展的？

    Evidence-based guideline.

    研究了多少人、动物或样本？

    Not applicable.

    实际发现了什么？

    Rec 1.7.1: offer multiple daily injection basal-bolus insulin regimens as the regimen of choice for all adults with T1D. Rec 1.10.1: consider ketone monitoring as part of sick-day rules. Recs 1.10.5-1.10.7: use isotonic saline for fluid replacement in DKA and give intravenous insulin by infusion. Misdiagnosis of T1D as T2D 'could lead to the person not receiving insulin treatment and a subsequent risk of diabetic ketoacidosis'.

    观察到的效应有多大？

    Not applicable.

    研究结果对日常生活意味着什么？

    UK guideline: insulin is standard for all adults with T1D; DKA treated with IV saline and IV insulin.

    该研究有哪些局限？

    Guideline.

    它对 Elawady 的具体说法说明了什么？

    Contradicts insulin-free management.

    研究结果是否适用于德国和欧洲？

    UK.

    从该研究中明确不能得出什么结论？

    Not applicable.

    科学细节 →

  • NICE guideline NG18: Diabetes (type 1 and type 2) in children and young people: diagnosis and management

    National Institute for Health and Care Excellence (NICE). NICE guideline 2015
    指南 / 立场声明独立交叉核查已核查全文★ 关键研究

    UK paediatric guideline: insulin from diagnosis; DKA needs urgent hospital IV fluids and insulin; honeymoon phase is temporary.

    DKA is serious; IV fluids and IV insulin.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    National guidance.

    研究是如何开展的？

    Evidence-based guideline.

    研究了多少人、动物或样本？

    Not applicable.

    实际发现了什么？

    Rec 1.2.18: offer children and young people with T1D a multiple daily injection basal-bolus insulin regimen from diagnosis. Recs 1.2.82-1.2.83: sick-day rules including blood ketone monitoring; offer blood ketone strips and meter. Rec 1.4.3: children taking insulin may develop DKA with normal blood glucose. Rec 1.4.6: explain that DKA is serious and needs urgent hospital assessment. Rec 1.4.21: treat DKA with intravenous fluids and intravenous insulin if the child is not alert, nauseated/vomiting or clinically dehydrated. Rec 1.2.25: explain the partial remission ('honeymoon') phase with low insulin needs.

    观察到的效应有多大？

    Not applicable.

    研究结果对日常生活意味着什么？

    UK paediatric guideline: insulin from diagnosis; DKA needs urgent hospital IV fluids and insulin; honeymoon phase is temporary.

    该研究有哪些局限？

    Guideline.

    它对 Elawady 的具体说法说明了什么？

    Contradicts insulin-free management.

    研究结果是否适用于德国和欧洲？

    UK.

    从该研究中明确不能得出什么结论？

    Not applicable.

    科学细节 →

结果不一或不明确的研究 (2)

  • A small Chinese trial of dexamethasone in ketoacidosis with pancreatitis

    Zhang J et al.. Medicine (Baltimore) 2023 · PMID 37832092 · DOI 10.1097/MD.0000000000035320
    随机对照试验独立交叉核查已核查全文★ 关键研究

    The trial reported better results with dexamethasone, but its numbers are physiologically implausible and it did not replace insulin and fluids.

    Strongest 'supporting' item found for steroids: tests dexamethasone as add-on in DKA with pancreatitis, not as replacement for insulin/fluids; data implausible.

    该研究是否支持这一具体说法？ 否 · 方法学质量: 极低 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Test dexamethasone in DKA with acute pancreatitis.

    研究是如何开展的？

    Single-centre randomised trial.

    研究了多少人、动物或样本？

    106 patients.

    实际发现了什么？

    Reported better labs and fewer adverse events with dexamethasone.

    观察到的效应有多大？

    Glucose 9.5 vs 14.6 mmol/L (reported).

    研究结果对日常生活意味着什么？

    This does not show that cortisone can treat ketoacidosis.

    该研究有哪些局限？

    Implausible pH data; unclear methods; no registration.

    它对 Elawady 的具体说法说明了什么？

    Cannot support steroid-only treatment of DKA.

    研究结果是否适用于德国和欧洲？

    Not applicable.

    从该研究中明确不能得出什么结论？

    Cannot be used to change DKA treatment.

    科学细节 →

  • Children with ketoacidosis in Middle Eastern intensive care units

    Ali NM et al.. Cureus 2026 · PMID 41859577 · DOI 10.7759/cureus.103735
    Meta分析独立交叉核查已核查摘要★ 关键研究

    More than a third had severe ketoacidosis, but none died with intensive-care treatment.

    Treated DKA has very low mortality (kernel of 'nobody dies'), but only because of insulin, fluids and ICU care.

    该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 低 · 证据确定性：见该说法的总体评估

    原始文献 · 科学细节

    研究通俗解读
    研究人员想了解什么？

    Summarise paediatric DKA outcomes in Middle Eastern ICUs.

    研究是如何开展的？

    Systematic review of 6 studies.

    研究了多少人、动物或样本？

    919 children (Saudi Arabia, Egypt, Iran).

    实际发现了什么？

    37% severe; 0 deaths with ICU care; frequent kidney injury.

    观察到的效应有多大？

    Mortality 0% (upper bound about 0.4%).

    研究结果对日常生活意味着什么？

    Ketoacidosis is survivable when treated promptly in hospital.

    该研究有哪些局限？

    Small, low-quality evidence.

    它对 Elawady 的具体说法说明了什么？

    Partly explains 'I never saw anyone die' but only for treated DKA.

    研究结果是否适用于德国和欧洲？

    Similar to European results.

    从该研究中明确不能得出什么结论？

    Cannot show what happens without treatment.

    科学细节 →

地区背景

德国 / 欧盟

German and European emergency practice follows the same consensus (EASD and JBDS are co-authors of I-INS-07).

埃及

DKA is a common cause of emergency admission of children and young adults with diabetes in Egypt and the region; delayed treatment increases mortality. Advice to avoid hospitals and insulin is particularly dangerous where access to care is already delayed.

在我的国家适用什么？

一般科学评估

错误 糖尿病酮症酸中毒（DKA）不加治疗会致命，主要由缺乏胰岛素引起；胰岛素、补液和补钾能挽救生命，而可的松和不吃不喝的禁食会使病情恶化。

该说法涉及生物学或医学关系。上述科学评估不论在哪个国家都适用；各国食品数据不会改变这一评估。

参考文献

  1. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report.. Umpierrez GE et al.. Diabetes Care 2024 · PMID 39052901 · DOI 10.2337/dci24-0032
  2. Diabetic ketoacidosis.. Dhatariya KK et al.. Nat Rev Dis Primers 2020 · PMID 32409703 · DOI 10.1038/s41572-020-0165-1
  3. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.. American Diabetes Association Professional Practice Committee for Diabetes* . Diabetes Care 2026 · PMID 41358894 · DOI 10.2337/dc26-S006
  4. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program.. Erondu N et al.. Diabetes Care 2015 · PMID 26203064 · DOI 10.2337/dc15-1251
  5. Diabetes in urban African-Americans. I. Cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis.. Musey VC et al.. Diabetes Care 1995 · PMID 7497857 · DOI 10.2337/diacare.18.4.483
  6. Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors.. Randall L et al.. Diabetes Care 2011 · PMID 21775761 · DOI 10.2337/dc11-0701
  7. Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis.. Kuppermann N et al.. N Engl J Med 2018 · PMID 29897851 · DOI 10.1056/NEJMoa1716816
  8. Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004-2017.. O'Reilly JE et al.. Diabetologia 2020 · PMID 32451572 · DOI 10.1007/s00125-020-05173-w
  9. Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis.. Burge MR et al.. Metabolism 2001 · PMID 11229425 · DOI 10.1053/meta.2001.20194
  10. Presentations, Complications, and Challenges Encountered During Management of Type 1 Diabetes in Egyptian Children During COVID-19 Pandemic: A Single-Center Experience.. Abdou M et al.. Front Endocrinol (Lausanne) 2022 · PMID 35360079 · DOI 10.3389/fendo.2022.814991
  11. 16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2026.. American Diabetes Association Professional Practice Committee for Diabetes. Diabetes Care 2026 · PMID 41358892 · DOI 10.2337/dc26-S016
  12. The management of diabetic ketoacidosis in adults-An updated guideline from the Joint British Diabetes Society for Inpatient Care.. Dhatariya KK et al. (JBDS-IP). Diabet Med 2022 · PMID 35224769 · DOI 10.1111/dme.14788
  13. Why were "starvation diets" promoted for diabetes in the pre-insulin period?. Mazur A. Nutr J 2011 · PMID 21396115 · DOI 10.1186/1475-2891-10-23
  14. NICE guideline NG17: Type 1 diabetes in adults: diagnosis and management. National Institute for Health and Care Excellence (NICE). NICE guideline 2015
  15. NICE guideline NG18: Diabetes (type 1 and type 2) in children and young people: diagnosis and management. National Institute for Health and Care Excellence (NICE). NICE guideline 2015
  16. Clinical efficacy of dexamethasone on diabetic ketoacidosis complicated with acute pancreatitis: A randomized controlled study.. Zhang J et al.. Medicine (Baltimore) 2023 · PMID 37832092 · DOI 10.1097/MD.0000000000035320
  17. Prevalence, Clinical Profile, and Outcomes of Diabetic Ketoacidosis (DKA) in Pediatric ICU Patients in the Middle East: A Systematic Review and Meta-Analysis.. Ali NM et al.. Cureus 2026 · PMID 41859577 · DOI 10.7759/cureus.103735

← 返回概览